改良悬雍垂腭咽成形术后满意度与副作用的长期评估
本研究为前瞻性干预研究,65例不适合手术治疗的阻塞性睡眠呼吸暂停(OSA)患者接受改良悬雍垂腭咽成形术(UPPP)。术后6个月和24个月问卷显示满意度分别为96%和83%,推荐手术分别为98%和92%,副作用发生率分别为38%和31%。术后9年电话访谈显示副作用不再构成问题。
要点
- 改良UPPP术后24个月,83%患者满意,92%推荐手术,但31%存在副作用。
- 术后高AHI和ESS评分与不满意显著相关,副作用发生与不满意无显著相关。
- 年轻患者推荐手术率更高、副作用更少;9年后副作用不再构成问题。
核心结论
- 绝大多数OSA患者术后24个月对改良UPPP满意,尽管三分之一存在副作用。
- 年轻患者副作用少于年长患者,OSA疗效更好的患者也更满意。
- 术后9年副作用不再构成问题。
研究设计与样本
- 前瞻性干预研究,纳入65例呼吸暂停低通气指数(AHI)≥15、体重指数<36 kg/m2、Epworth嗜睡量表(ESS)评分≥8且非手术治疗失败的OSA患者,行改良UPPP。
- 术后6个月和24个月进行患者问卷,并与年龄、体重指数、ESS和AHI评分进行相关性分析。
- 对术后24个月报告副作用和/或后悔手术的患者,在术后9年进行电话访谈。
主要发现
- 问卷应答率在6个月和24个月随访时分别为80%和74%。
- 应答者中,术后6个月和24个月满意度分别为96%和83%,推荐手术分别为98%和92%。
- 副作用(球感、黏液、嗓音和吞咽障碍)发生率在6个月和24个月分别为38%和31%。
- 不满意与术后高AHI和ESS评分显著相关,但与副作用发生无显著相关。
- 年轻受试者比年长受试者推荐手术率更高、副作用发生率更低;术后9年电话访谈中,16例选定患者中14例应答,报告轻微或无副作用。
临床怎么用
- 作者认为,改良UPPP术后绝大多数OSA患者满意,尽管部分存在副作用;年轻患者副作用更少,OSA疗效更好的患者更满意。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: We have previously shown that modified uvulopalatopharyngoplasty (UPPP) is effective to treat obstructive sleep apnea (OSA) and that the effect is stable after 24 months. This continuous report includes questionnaires and phone interviews. STUDY DESIGN: Prospective intervention study. METHODS: Sixty-five patients with apnea-hypopnea index (AHI) score ≥ 15, body mass index <36 kg/m2 , and Epworth Sleepiness Scale (ESS) score ≥ 8 underwent modified UPPP after failing nonsurgical treatment. The results from a patient questionnaire at 6 and 24 months after surgery were correlated with age, body mass index, and ESS and AHI scores. Patients reporting side effects and/or regretting the surgery after 24 months were selected for phone interviews 9 years after surgery. RESULTS: The response rate was 80% and 74% at the 6- and 24-month follow-ups, respectively. Of those who responded to the questionnaire, 96% and 83% were satisfied after 6 and 24 months, respectively; 98% and 92% recommended the surgery. Side effects (globus, mucus, and voice and swallowing disorders) occurred in 38% and 31%, respectively. Dissatisfaction correlated significantly with high postoperative AHI and ESS scores, but not with occurrence of side effects. Younger subjects had a higher rate of recommendation and lower rate of side effects than did older subjects. Phone interviews after 9 years were responded to by 14 of 16 selected patients, and the responders reported minor or no side effects. CONCLUSIONS: The vast majority of the OSA patients were satisfied 24 months after surgery, even though a third of them were experiencing side effects. Younger patients had fewer side effects than did older patients. Patients with better OSA outcomes were also more satisfied. After 9 years the side effects were no longer problematic. LEVEL OF EVIDENCE: 2b Laryngoscope, 130:263-268, 2020.
引用
- Friberg D, Sundman J, Browaldh N, et al. Long-term evaluation of satisfaction and side effects after modified uvulopalatopharyngoplasty. Laryngoscope. 2019. PMID: 30861139. doi:10.1002/lary.27917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。